Pharmaceutical formulations for parenteral administration comprising epothilone

(19)

(11)

EP 1 800 664 B8

(12)	CORRECTED EUROPEAN PATENT SPECIFICATION
	Note: Bibliography reflects the latest situation

(15)	Correction information:
	Corrected version no 1 (W1 B1)

(48)	Corrigendum issued on:
	15.12.2010 Bulletin 2010/50

(45)	Mention of the grant of the patent:
	08.04.2009 Bulletin 2009/15

(21)	Application number: 07102856.7

(22)	Date of filing: 03.02.1999

(51)

International Patent Classification (IPC):

A61K 9/08^(2006.01)
A61K 47/10^(2006.01)
A61K 31/335^(2006.01)

A61K 9/19^(2006.01)
A61K 47/18^(2006.01)
A61K 31/365^(2006.01)

(54)	Pharmaceutical formulations for parenteral administration comprising epothilone Pharmazeutische Zubereitungen zur parenteralen Verabreichung enthaltend Epothilon Compositions pharmaceutiques pour l'administration parenterale comprenant une epothilone

(84)	Designated Contracting States:
	AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU NL PT SE

(30)

Priority:

05.02.1998 GB 9802451

(43)	Date of publication of application:
	27.06.2007 Bulletin 2007/26

(62)	Application number of the earlier application in accordance with Art. 76 EPC:
	99907491.7 / 1052974

(73)	Proprietors:
	Novartis AG 4002 Basel (CH) Designated Contracting States: BE CH CY DE DK ES FI FR GB GR IE IT LI LU NL PT SE Novartis Pharma GmbH 1230 Wien (AT) Designated Contracting States: AT

(72)	Inventor:
	van Hoogevest, Peter 4416, Bubendorf (CH)

(74)	Representative: Breuer, Markus
	Breuer & Müller Partnerschaft Patentanwälte Heimeranstrasse 35 80339 München 80339 München (DE)

(56)

References cited: :

WO-A-98/25929
WO-A1-93/10121
WO-A1-97/33552

WO-A-99/39694
WO-A1-97/19086

Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).